Hold the thread.

Semax is a synthetic seven-amino-acid peptide with the sequence Met–Glu–His–Phe–Pro–Gly–Pro. It is related to an ACTH fragment but does not contain the sequence responsible for ACTH's adrenal hormone activity.

Researchers have studied Semax in attention, memory, neuronal signaling, and ischemia models. A 24-person resting-state fMRI experiment measured short-term changes in the brain's default mode network after intranasal Semax. That experiment measured network activity, not better day-to-day focus or clinical outcomes.

In rat hippocampus, one intranasal dose was followed by 1.4-fold higher BDNF protein, 1.6-fold higher trkB phosphorylation, 3-fold higher exon III BDNF mRNA, and 2-fold higher trkB mRNA. Those are animal biomarker results, not human treatment outcomes.

The planned Rebody format is a prescription nasal spray. Orders remain closed until the exact formula, metered pump delivery, price, and states served are final.

Before ordering opens, the label must identify whether the prescription contains Semax free base or Semax acetate, plus the concentration, metered delivery, directions, storage, beyond-use date, and dispensing pharmacy.

No. Semax is not an FDA-approved drug. A compounded Semax prescription would be prepared for an individual patient by a licensed U.S. compounding pharmacy.

No. Orders are closed. Join the waitlist for the exact substance, concentration, pump delivery, directions, price, states served, and availability date.